Anne Dørum

5.6k citations

71 papers · 1.8k indexed · h-index 24

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments

Papers in ⓘ

Reproductive Medicine 36
- Ovarian cancer diagnosis and treatment 35
Obstetrics and Gynecology 10
- Endometrial and Cervical Cancer Treatments 8

Co-authors: Alv A. Dahl (10 shared papers)Claes G. Tropé (13 shared papers)Trond Melbye Michelsen (7 shared papers)Astrid H. Liavaag (8 shared papers)Pål Møller (15 shared papers)D. Gareth Evans (2 shared papers)Diane Provencher (5 shared papers)Jean‐Sébastien Brunet (2 shared papers)
Journals: Acta Obstetricia Et Gynecologica Scandinavica (9 papers)Gynecologic Oncology (6 papers)International Journal of Gynecological Cancer (6 papers)European Journal of Cancer (5 papers)Journal of Clinical Oncology (5 papers)
Partner nations: Norway Sweden United States

In The Last Decade

Anne Dørum

71 papers receiving 1.8k citations

Peers

Countries citing papers authored by Anne Dørum

Since Specialization

Citations

This map shows the geographic impact of Anne Dørum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Dørum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Dørum more than expected).

Fields of papers citing papers by Anne Dørum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Dørum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Dørum. The network helps show where Anne Dørum may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Dørum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Dørum Line = papers co-authored together Anne Dørum links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 71 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Oral Contraceptives and the Risk of Hereditary Ovarian Cancer New England Journal of Medicine ·Steven A. Narod, Harvey A. Risch, Roxana Moslehi, Anne Dørum, Susan L. Neuhausen, Håkan Olsson, Diane Provencher, Paolo Radice, D. Gareth Evans, Susan Bishop, Jean‐Sébastien Brunet, Bruce A.J. Ponder, Jan G.M. Klijn	1998	385
2	Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers Journal of Medical Genetics ·D. Gareth Evans, Katja N. Gaarenstroom, D. Stirling, A Shenton, Lovise Mæhle, Anne Dørum, M Steel, Fiona Lalloo, Jaran Apold, Mary Porteous, Hans F. A. Vasen, Christi J. van Asperen, Pål Møller	2008	96
3	Evaluation of endometrial thickness measured by endovaginal ultrasound in women with postmenopausal bleeding Acta Obstetricia Et Gynecologica Scandinavica ·Anne Dørum, Gitte Kristensen, Anton Langebrekke, Torgrim Sørnes, Ø. Skaar	1993	76
4	Bilateral oophorectomy before 50 years of age is significantly associated with the metabolic syndrome and Framingham risk score: A controlled, population-based study (HUNT-2) Gynecologic Oncology ·Anne Dørum, Serena Tonstad, Astrid H. Liavaag, Trond Melbye Michelsen, Bjørn Hildrum, Alv A. Dahl	2008	68
5	A controlled study of sexual activity and functioning in epithelial ovarian cancer survivors. A therapeutic approach Gynecologic Oncology ·Astrid H. Liavaag, Anne Dørum, Trine Bjøro, Halldis Oksefjell, Sophie D. Fosså, Claes G. Tropé, Alv A. Dahl	2007	65
6	Controlled Study of Fatigue, Quality of Life, and Somatic and Mental Morbidity in Epithelial Ovarian Cancer Survivors: How Lucky Are the Lucky Ones? Journal of Clinical Oncology ·Astrid H. Liavaag, Anne Dørum, Sophie D. Fosså, Claes G. Tropé, Alv A. Dahl	2007	65
7	Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: A controlled observational study European Journal of Cancer ·Trond Melbye Michelsen, Are Hugo Pripp, Serena Tonstad, Claes G. Tropé, Anne Dørum	2008	53
8	Prevalence and histologic diagnosis of adnexal cysts in postmenopausal women: An autopsy study American Journal of Obstetrics and Gynecology ·Anne Dørum, Gustav Peter Blom, Erling Ekerhovd, S. Granberg	2005	52
9	Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique Clinical & Experimental Immunology ·Sissel E. Monstad, Anette Storstein, Anne Dørum, Anette Knudsen, Per Eystein Lønning, Helga B. Salvesen, Jan Aarseth, Christian A. Vedeler	2006	41
10	BRCA1 mutations in ovarian cancer and borderline tumours in Norway: a nested case–control study British Journal of Cancer ·Tone Bjørge, A. Kathrine Lie, Eivind Hovig, Randi E. Gislefoss, Steven G. Hansen, Egil Jellum, Hilde Langseth, Kjell Nustad, Claes G. Tropé, Anne Dørum	2004	40
11	Therapy effect of either paclitaxel or cyclophosphamide combination treatment in patients with epithelial ovarian cancer and relation to TP53 gene status British Journal of Cancer ·Birgitte Smith‐Sørensen, J. Kærn, Ruth Holm, Anne Dørum, Claes G. Tropé, A‐L Børresen‐Dale	1998	39
12	Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study Annals of Oncology ·Jean‐Emmanuel Kurtz, Marie‐Christine Kaminsky, Anne Floquet, Anne-Sophie Veillard, Rainer Kimmig, Anne Dørum, Laurie Elit, Martin Buck, Edgar Petru, N. Reed, Giovanni Scambia, N. Varsellona, Chris Brown, Éric Pujade-Lauraine	2011	37
13	Early detection of familial ovarian cancer European Journal of Cancer ·Anne Dørum, Gunnar B. Kristensen, Vera M. Abeler, Claes G. Tropé, Pål Møller	1996	37
14	A controlled study of mental distress and somatic complaints after risk-reducing salpingo-oophorectomy in women at risk for hereditary breast ovarian cancer Gynecologic Oncology ·Trond Melbye Michelsen, Anne Dørum, Alv A. Dahl	2009	36
15	Chemotherapy vs tamoxifen in platinum-resistant ovarian cancer: a phase III, randomised, multicentre trial (Ovaresist) British Journal of Cancer ·Kristina Lindemann, Emma Gibbs, Elisabeth Åvall‐Lundqvist, René dePont Christensen, Kathrine Woie, M. Kalling, Annika Auranen, Seija Grénman, Thomas Hoegberg, Per Rosenberg, Tone Skeie-Jensen, Elisabet Hjerpe, Anne Dørum, Val Gebski, Gunnar B. Kristensen	2017	36
16	Oral Contraceptives and the Risk of Hereditary Ovarian Cancer Obstetrical & Gynecological Survey ·Steven A. Narod, Harvey A. Risch, Roxana Moslehi, Anne Dørum, Susan L. Neuhausen, Håkan Olsson, Diane Provencher, Paolo Radice, Susan Bishop, Jean‐Sébastien Brunet, Bruce A.J. Ponder	1999	34
17	Efficacy and safety of niraparib as maintenance treatment in older patients (≥ 70 years) with recurrent ovarian cancer: Results from the ENGOT-OV16/NOVA trial Gynecologic Oncology ·Michel Fabbro, Kathleen N. Moore, Anne Dørum, Anna V. Tinker, Sven Mahner, Isabel Bover, Susana Banerjee, Germana Tognon, Frédéric Goffin, Ronnie Shapira‐Frommer, Robert M. Wenham, Kristina Hellman, Diane Provencher, Philipp Harter, Isabel Palacio Vázquez, Philippe Follana, Mario Javier Pineda, Mansoor Raza Mirza, Sebastien Hazard, Ursula A. Matulonis	2019	32
18	Three per cent of Norwegian Ovarian Cancers are caused by BRCA1 1675delA or 1135insA European Journal of Cancer ·Anne Dørum, Eivind Hovig, Claes G. Tropé, Mats Inganäs, Pål Møller	1999	32
19	Prospectively detected cancer in familial breast/ovarian cancer screening Acta Obstetricia Et Gynecologica Scandinavica ·Anne Dørum, Ketil Heimdal, Kjell Løvslett, Gunnar B. Kristensen, Lars Jul Hansen, Roar Sandvei, Arne Schiefloe, Bjørn Hagen, A. Himmelmann, F Jerve, Kaare Shetelig, Ingmar Fjærestad, C. Tropé, Pål Møller	1999	30
20	Penetrances of BRCA1 1675delA and 1135insA with Respect to Breast Cancer and Ovarian Cancer The American Journal of Human Genetics ·Anne Dørum, Ketil Heimdal, Eivind Hovig, Mats Inganäs, Pål Møller	1999	25

About Anne Dørum

Anne Dørum is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Genetics, Cancer Research and Oncology, having authored 71 papers that have together received 1.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (35 papers), BRCA gene mutations in cancer (30 papers), Cancer Genomics and Diagnostics (11 papers), Genetic factors in colorectal cancer (10 papers), Endometrial and Cervical Cancer Treatments (8 papers), PARP inhibition in cancer therapy (7 papers), Cancer-related Molecular Pathways (6 papers) and Family Support in Illness (6 papers). The work is most often cited by research in Reproductive Medicine (882 citations), Obstetrics and Gynecology (277 citations), Genetics (865 citations), Oncology (553 citations) and Cancer Research (265 citations). Anne Dørum has collaborated with scholars based in Norway, Sweden and United States. Frequent co-authors include Alv A. Dahl, Claes G. Tropé, Trond Melbye Michelsen, Astrid H. Liavaag, Pål Møller, D. Gareth Evans, Diane Provencher, Jean‐Sébastien Brunet, Sophie D. Fosså and Susan L. Neuhausen. Their work appears in journals such as Acta Obstetricia Et Gynecologica Scandinavica, Gynecologic Oncology, International Journal of Gynecological Cancer, European Journal of Cancer and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact